<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab2" content-type="sidewaystable" orientation="portrait" position="float" class="table-wrap">
 <label class="label">Table 2</label>
 <caption class="caption">
  <p class="p">Principal characteristics of clinical studies carried out with 
   <italic class="italic">Citrus aurantium</italic> essential oil.
  </p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="left" rowspan="1" colspan="1" class="th">
     <bold class="bold">Authors</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Indication</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Study </bold>
     <bold class="bold">design</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Subjects (number and age)</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Treatment</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Principal endpoints</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Adverse </bold>
     <bold class="bold">effects</bold>
    </th>
    <th align="center" rowspan="1" colspan="1" class="th">
     <bold class="bold">Outcome</bold>
    </th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Fernandes Pimenta, et al., 2016</td>
    <td align="center" rowspan="1" colspan="1" class="td">Anxiety in patients with chronic myeloid leukemia (CML)</td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled study</td>
    <td align="center" rowspan="1" colspan="1" class="td">N = 42 of both sexes.
     <break class="break"/>Average age: 45 ± 5 years. 
     <break class="break"/>
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Participants were randomly divided into three groups. 
     <break class="break"/>Group 1 received 10 mg diazepam as oral dose;
     <break class="break"/>Group 2 received 
     <italic class="italic">C. aurantium</italic> essential oil (EO) 10 mL diffused in the room through an electric dispenser. 
     <break class="break"/>Group 3 (placebo) was exposed to the vaporization of saline solution. 
     <break class="break"/>In the last two groups, the exposure lasted 30min.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">The evaluation was performed through psychometric scales STAI-S [State-Trait Anxiety Inventory (STAI)] and physiological measurements (blood pressure and cardiac and respiratory frequency).
     <break class="break"/>
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Not reported.</td>
    <td align="center" rowspan="1" colspan="1" class="td">Inhalation of 
     <italic class="italic">C. aurantium</italic> was associated with a decrease in
     <break class="break"/>the STAI-S scores, suggesting an anxiolytic effect.
     <break class="break"/>In patients exposed to 
     <italic class="italic">C. aurantium</italic>EO or with diazepam, there was a decrease in the systolic blood pressure. 
     <break class="break"/>A change in all the physiological
     <break class="break"/>measurements was observed in the group exposed to 
     <italic class="italic">C. aurantium</italic>.
     <break class="break"/>The results showed that
     <break class="break"/>
     <italic class="italic">C. aurantium</italic> exhibits an anxiolytic effect and reduces the signs and symptoms associated with anxiety in patients
     <break class="break"/>with CML.
    </td>
   </tr>
   <tr class="tr">
    <td colspan="8" rowspan="1" class="td">
     <hr class="hr"/>
    </td>
   </tr>
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Pei-Hsin et al., 2010</td>
    <td align="center" rowspan="1" colspan="1" class="td">Anxiety, stress and physiological parameters in patients subjected to colonoscopy</td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled trial.</td>
    <td align="center" rowspan="1" colspan="1" class="td">N = 27 subjects:
     <break class="break"/>13 in control group and 14 in Neroli group.
     <break class="break"/>Average age: 52.26 ± 17.79 years.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Aromatherapy
     <break class="break"/>was then carried out by inhalation of Sunflower oil
     <break class="break"/>(control group) and Neroli oil (experimental group).
     <break class="break"/>One drop (50 ml) of Sunflower oil or Neroli oil placed in handhold-nebulizer was supplied for five minutes.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">The anxiety index
     <break class="break"/>was evaluated by STAI-S before aromatherapy and after colonoscopy; 
     <break class="break"/>postprocedural pain index was measured by visual analogue scale (VAS). 
     <break class="break"/>Systolic and
     <break class="break"/>diastolic blood pressure, heart rate and respiratory
     <break class="break"/>rate were evaluated before and after aromatherapy.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Not reported</td>
    <td align="center" rowspan="1" colspan="1" class="td">There was no
     <break class="break"/>significant difference of procedural anxiety by STAI-S score
     <break class="break"/>and procedural pain by VAS before or after aromatherapy. The physiological
     <break class="break"/>parameters showed a significant lower pre- and postprocedural systolic blood pressure in Neroli group than control group.
    </td>
   </tr>
   <tr class="tr">
    <td colspan="8" rowspan="1" class="td">
     <hr class="hr"/>
    </td>
   </tr>
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Akhlaghi et al., 2011</td>
    <td align="center" rowspan="1" colspan="1" class="td">Anxiety in ASA
     <break class="break"/>physical status I (healthy) patients scheduled for lower limb minor operation
     <break class="break"/>under general anesthesia.
     <break class="break"/>
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled double-blind study</td>
    <td align="center" rowspan="1" colspan="1" class="td">60 outpatients, scheduled for elective minor surgery
     <break class="break"/>Age range: 15-60 years.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Participants were divided into two groups of 30 receiving oral 
     <italic class="italic">Citrus aurantium</italic> blossom distillate (CABd 1 mL.kg-1) or placebo, respectively, two
     <break class="break"/>hours before surgery.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Preoperative anxiety
     <break class="break"/>was assessed using both State-Trait Anxiety Inventory (STAI state)
     <break class="break"/>and Amsterdam Preoperative Anxiety and Information
     <break class="break"/>Scale (APAIS). Heart rate and
     <break class="break"/>blood pressure were measured two hours before
     <break class="break"/>operation just before premedication.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Not observed.</td>
    <td align="center" rowspan="1" colspan="1" class="td">Patients treated with CABd were significantly less anxious than patients of placebo group (p &lt; 0.05).</td>
   </tr>
   <tr class="tr">
    <td colspan="8" rowspan="1" class="td">
     <hr class="hr"/>
    </td>
   </tr>
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Hasheminia et al., 2014</td>
    <td align="center" rowspan="1" colspan="1" class="td">Moderate and high anxiety before and during surgical removal of an impacted
     <break class="break"/>mandibular third molar.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled clinical trial.</td>
    <td align="center" rowspan="1" colspan="1" class="td">N = 56;
     <break class="break"/>Age range: 15-45; mean age fragrance group: 26.4 ± 5.3 years, mean age no fragrance group: 27.5 ± 5.7 years.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Patients were divided into two groups: fragrance group (19 males, 9 females), control group 
     <break class="break"/>(12 males, 16 females).
     <break class="break"/>Patients of the fragrance condition were exposed to 5 drops (0.25 mL) of 
     <italic class="italic">C. aurantium</italic> essential oil poured in 5 L of water and diffused using an electrical dispenser.
     <break class="break"/>Patients in the control condition were exposed in the same environment to diffusion of water without fragrance. All the patients (control and experimental) waited about 10 min in the waiting room.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">The dental anxiety scale (DAS) questionnaire was used to determine the anxiety level of the patients prior to surgery
     <break class="break"/>Mean blood pressure, respiratory rate, and pulse rate were also evaluated.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Not reported</td>
    <td align="center" rowspan="1" colspan="1" class="td">Orange fragrance is effective in reducing anxiety linked to surgical
     <break class="break"/>removal of impacted mandibular third molar. Mean blood pressure, respiratory rate, and pulse rate, during surgery, were significantly reduced. 
    </td>
   </tr>
   <tr class="tr">
    <td colspan="8" rowspan="1" class="td">
     <hr class="hr"/>
    </td>
   </tr>
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Namazi et al., 2014</td>
    <td align="center" rowspan="1" colspan="1" class="td">Anxiety during labor in primiparous pregnant women.</td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled trial</td>
    <td align="center" rowspan="1" colspan="1" class="td">126 primiparous women divided into two groups: aromatherapy (n = 63) and control (n = 63).
     <break class="break"/>Age range: 18-35 years. Mean age: 26.43 ± 3.21 aroma therapy group; 26.60 ± 3.40.
     <break class="break"/>
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">100 mL of the distillate contained 8 mL 
     <italic class="italic">C. aurantium </italic>essential oil. Gauzes impregnated with 4 mL of 
     <italic class="italic">C. aurantium </italic>distillate and normal saline were attached to the collar of the participants in the aromatherapy and control groups, respectively. 
     <break class="break"/>The gauzes were changed every 30 minutes.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Intensity of anxiety was measured at baseline and after the intervention at dilations of 3-4 and 6-8 cm. Data were collected using a demographic and obstetric questionnaire, an examination and observation checklist including vital signs, vaginal examination, uterine contractions, and fetal heart rate, and Spielberger state-trait anxiety questionnaire.</td>
    <td align="center" rowspan="1" colspan="1" class="td">Not observed</td>
    <td align="center" rowspan="1" colspan="1" class="td">The levels of anxiety at dilations of 3-4 and 6-8 cm were significantly lower in the aromatherapy group compared with the control group.</td>
   </tr>
   <tr class="tr">
    <td colspan="8" rowspan="1" class="td">
     <hr class="hr"/>
    </td>
   </tr>
   <tr class="tr">
    <td align="left" rowspan="1" colspan="1" class="td">Chaves Neto et al., 2017</td>
    <td align="center" rowspan="1" colspan="1" class="td">Anxiolytic effect of 
     <italic class="italic">Citrus aurantium L</italic>. in Crack Users subjected to Simulated Public Speaking (SPS).
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Randomized controlled clinical trial.</td>
    <td align="center" rowspan="1" colspan="1" class="td">51 volunteers,
     <break class="break"/>subdivided into three groups: 
     <break class="break"/>Control Group: non-crack users who were not internal to the therapeutic communities (n=17) mean age of 28 years (± 2.01);
     <break class="break"/>
     <break class="break"/>Nonusers EO Group: non-crack users who were not internal to the therapeutic communities (n=17),
     <break class="break"/>mean age of 24 years
     <break class="break"/>(± 0.7282)
     <break class="break"/>Users EO Group, users of crack that were internal to the therapeutic communities (n=17), mean age of 30
     <break class="break"/>years (± 2,125).
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">
     <italic class="italic">Citrus aurantium</italic> essential oil was administered by nebulization, 2 drops
     <break class="break"/>(0.1 mL) in 1.9mL of distilled water solution with an emulsifier (Tween 80 at 12%), for each subject. 
     <break class="break"/>Control Group experienced received only the distilled water with an emulsifier.
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">The Simulated Public Speaking (SPS) method was used. Physiological measures were assessed at specific phases during the experiment.
     <break class="break"/>Psychological measures of anxiety were assessed using the Trait-State Anxiety Inventory (IDATE) and the Humor Analog Scale (HAS). 
     <break class="break"/>
    </td>
    <td align="center" rowspan="1" colspan="1" class="td">Not reported</td>
    <td align="center" rowspan="1" colspan="1" class="td">Nebulization of C
     <italic class="italic">itrus aurantium</italic> L. EO provided an acute anxiolytic effect in crack cocaine users exposed to SPS.
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
